Clinical Trials
26 trialsVERDI
Dana-Farber Cancer Institute
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
A Study of DEG6498 in Participants With Solid Tumors
Degron Therapeutics Co.
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Vanderbilt-Ingram Cancer Center
iCaRe2
University of Nebraska
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
STEALTH-001
KaliVir Immunotherapeutics
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Psyence Australia Pty Ltd
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
EBNK-ST-001
Essen Biotech
ELEPHAS-05
Elephas
LIBERATE
University Health Network, Toronto
Immunobiome
University of Aarhus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Hadassah Medical Organization
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
DP-PAN-CANCER
Institut Claudius Regaud
EVIDENT
Sheffield Teaching Hospitals NHS Foundation Trust
MOHCCN-O
University Health Network, Toronto
MONITOR
Hospices Civils de Lyon
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
REGATA
N.N. Petrov National Medical Research Center of Oncology
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
ONCOPRO
Hospices Civils de Lyon